Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jeffrey Robert Ajer. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jeffrey Robert Ajer har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BMRN / BioMarin Pharmaceutical Inc. | EVP, Chief Commercial Officer | 66 767 |
US:NKTR / Nektar Therapeutics | Director | 34 153 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jeffrey Robert Ajer. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp NKTR / Nektar Therapeutics - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i NKTR / Nektar Therapeutics. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i NKTR / Nektar Therapeutics. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jeffrey Robert Ajer som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 66 767 | −6,97 | 82,91 | −414 550 | 5 535 652 |
2024-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 300 | 71 767 | 0,42 | 68,65 | 20 594 | 4 926 517 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −22 580 | 71 467 | −24,01 | 83,87 | −1 893 785 | 5 993 937 | |
2024-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −4 000 | 94 047 | −4,08 | 87,07 | −348 280 | 8 188 672 |
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 6 465 | 98 047 | 7,06 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 338 | 91 582 | 11,35 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 21 440 | 82 244 | 35,26 | ||||
2023-09-20 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
S - Sale | −4 359 | 34 153 | −11,32 | 0,69 | −3 008 | 23 566 | |
2023-08-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 60 804 | −7,60 | 90,00 | −450 000 | 5 472 360 |
2023-08-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 318 | 65 804 | 0,49 | 66,88 | 21 267 | 4 400 840 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −20 510 | 65 486 | −23,85 | 93,41 | −1 915 839 | 6 117 047 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 971 | 85 996 | −4,41 | 87,74 | −348 416 | 7 545 289 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 110 | 89 967 | 12,66 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 7 629 | 79 857 | 10,56 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 380 | 72 228 | 16,78 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 760 | 61 848 | 50,53 | ||||
2023-01-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −4 175 | 41 088 | −9,22 | 116,15 | −484 943 | 4 772 536 |
2023-01-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −44 825 | 45 263 | −49,76 | 115,65 | −5 184 191 | 5 234 847 |
2023-01-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 49 000 | 90 088 | 119,26 | 67,81 | 3 322 690 | 6 108 867 |
2022-11-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 000 | 41 088 | −6,80 | 86,12 | −258 360 | 3 538 499 |
2022-09-26 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
S - Sale | −4 198 | 38 512 | −9,83 | 3,16 | −13 266 | 121 698 | |
2022-09-20 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
A - Award | 10 200 | 42 710 | 31,37 | ||||
2022-08-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 000 | 44 088 | −6,37 | 95,62 | −286 860 | 4 215 695 |
2022-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −7 021 | 47 088 | −12,98 | 77,49 | −544 057 | 3 648 849 | |
2022-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 308 | 54 109 | −2,36 | 78,94 | −103 254 | 4 271 364 |
2022-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 340 | 55 417 | 0,62 | 62,41 | 21 218 | 3 458 409 | |
2022-04-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 180 | 55 077 | −2,10 | 82,47 | −97 315 | 4 542 200 |
2022-03-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 381 | 56 257 | −2,40 | 79,56 | −109 872 | 4 475 807 |
2022-03-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 618 | 57 638 | −2,73 | 79,43 | −128 518 | 4 578 186 |
2022-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −6 129 | 59 256 | −9,37 | 81,78 | −501 230 | 4 845 956 |
2022-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 073 | 65 385 | −3,07 | 81,00 | −167 913 | 5 296 185 |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 287 | 67 458 | −1,87 | 80,72 | −103 887 | 5 445 210 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 28 670 | 28 670 | |||||
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −8 418 | 68 745 | −10,91 | 78,27 | −658 877 | 5 380 671 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 940 | 77 163 | 18,31 | ||||
2022-03-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 370 | 65 223 | 16,78 | ||||
2021-10-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 739 | 55 853 | −4,67 | 73,60 | −201 590 | 4 110 781 |
2021-10-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 342 | 58 592 | 0,59 | 62,41 | 21 343 | 3 656 551 | |
2021-09-24 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Stock Option |
A - Award | 20 400 | 20 400 | |||||
2021-09-24 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
S - Sale | −3 665 | 32 510 | −10,13 | 17,78 | −65 164 | 578 028 | |
2021-09-24 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
A - Award | 10 200 | 36 175 | 39,27 | ||||
2021-04-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 537 | 58 250 | −2,57 | 78,81 | −121 131 | 4 590 682 |
2021-04-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 652 | 59 787 | −2,69 | 74,79 | −123 553 | 4 471 470 |
2021-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 181 | 61 439 | −1,89 | 76,30 | −90 110 | 4 687 796 |
2021-03-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 513 | 62 620 | −2,36 | 78,52 | −118 801 | 4 916 922 | |
2021-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 308 | 64 133 | −2,00 | 77,99 | −102 011 | 5 001 733 |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 287 | 65 441 | −1,93 | 77,21 | −99 369 | 5 052 700 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 26 400 | 26 400 | |||||
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 273 | 66 728 | −7,32 | 78,39 | −413 350 | 5 230 808 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 720 | 72 001 | 17,49 | ||||
2020-10-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 121 | 61 281 | −3,35 | 79,91 | −169 489 | 4 896 965 |
2020-09-30 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
S - Sale | X | −3 250 | 25 975 | −11,12 | 17,25 | −56 062 | 448 069 |
2020-09-25 |
|
4/A | NKTR |
NEKTAR THERAPEUTICS
Stock Option |
A - Award | 18 200 | 18 200 | |||||
2020-09-25 |
|
4/A | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
A - Award | 9 100 | 29 225 | 45,22 | ||||
2020-09-24 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Stock Option |
A - Award | 18 200 | 18 200 | |||||
2020-09-24 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
A - Award | 9 100 | 29 225 | 45,22 | ||||
2020-09-21 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
S - Sale | X | −2 250 | 20 125 | −10,06 | 19,74 | −44 415 | 397 268 |
2020-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −15 000 | 15 700 | −48,86 | |||
2020-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 63 402 | −19,13 | 124,00 | −1 860 000 | 7 861 848 |
2020-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 000 | 78 402 | 23,66 | 63,10 | 946 500 | 4 947 166 |
2020-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 338 | 63 402 | 0,54 | 62,59 | 21 154 | 3 968 078 | |
2020-04-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 407 | 63 064 | −3,68 | 79,98 | −192 512 | 5 043 859 |
2020-04-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 537 | 65 471 | −2,29 | 82,00 | −126 034 | 5 368 622 |
2020-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 618 | 67 008 | −2,36 | 78,47 | −126 964 | 5 258 118 |
2020-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 041 | 68 626 | −2,89 | 74,36 | −151 769 | 5 103 029 |
2020-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 599 | 70 667 | −4,85 | 73,05 | −262 907 | 5 162 224 | |
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 29 590 | 29 590 | |||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 380 | 74 266 | 16,25 | ||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −7 644 | 63 886 | −10,69 | 84,50 | −645 918 | 5 398 367 | |
2020-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 586 | 71 530 | 15,48 | ||||
2019-10-01 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
S - Sale | X | −2 375 | 22 375 | −9,60 | 18,06 | −42 892 | 404 092 |
2019-09-27 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Stock Option |
A - Award | 13 000 | 13 000 | |||||
2019-09-27 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
A - Award | 6 500 | 24 750 | 35,62 | ||||
2019-09-24 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
S - Sale | X | −2 250 | 18 250 | −10,98 | 20,24 | −45 540 | 369 380 |
2019-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 61 994 | 0,50 | 68,78 | 21 254 | 4 264 071 | |
2019-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 14 160 | 61 635 | 29,83 | ||||
2019-03-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 656 | 47 475 | −7,15 | 89,18 | −326 025 | 4 233 597 |
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 598 | 51 131 | −6,57 | 88,05 | −316 804 | 4 502 085 | |
2019-03-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 930 | 54 729 | −3,41 | 90,47 | −174 614 | 4 951 535 |
2019-03-25 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 589 | 56 659 | −4,37 | 89,62 | −232 020 | 5 077 638 |
2019-03-21 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 728 | 59 248 | −5,92 | 93,07 | −346 965 | 5 514 211 |
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 23 450 | 23 450 | |||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 370 | 62 976 | 17,48 | ||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −7 169 | 53 606 | −11,80 | 94,53 | −677 686 | 5 067 375 | |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −917 | 60 775 | −1,49 | 94,76 | −86 895 | 5 759 039 | |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 557 | 61 692 | 25,56 | ||||
2018-11-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −9 000 | 30 700 | −22,67 | |||
2018-11-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −600 | 49 135 | −1,21 | 94,35 | −56 611 | 4 635 966 |
2018-11-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −799 | 49 735 | −1,58 | 93,81 | −74 957 | 4 665 834 |
2018-11-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 400 | 50 534 | −4,53 | 92,21 | −221 297 | 4 659 589 |
2018-11-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 201 | 52 934 | −8,95 | 91,62 | −476 494 | 4 849 591 |
2018-11-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 9 000 | 58 135 | 18,32 | 63,10 | 567 900 | 3 668 318 |
2018-10-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 000 | 49 135 | −1,99 | 98,98 | −98 985 | 4 863 618 |
2018-10-01 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Stock Option |
A - Award | 9 500 | 9 500 | |||||
2018-10-01 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
A - Award | 4 750 | 20 500 | 30,16 | ||||
2018-09-21 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
S - Sale | X | −6 750 | 15 750 | −30,00 | 56,76 | −383 130 | 893 970 |
2018-06-13 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 436 | 50 135 | −2,78 | 90,31 | −129 685 | 4 527 692 |
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 414 | 51 571 | −2,67 | 92,07 | −130 187 | 4 748 142 | |
2018-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −309 | 52 914 | −0,58 | 85,96 | −26 562 | 4 548 487 |
2018-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 53 223 | 0,58 | 68,78 | 21 254 | 3 660 784 | |
2018-04-27 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 598 | 56 555 | −5,98 | 81,36 | −292 733 | 4 601 315 | |
2018-04-26 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 615 | 60 004 | 26,62 | ||||
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 119 | 52 914 | −3,85 | 80,12 | −169 774 | 4 239 470 |
2018-03-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 537 | 55 033 | −2,72 | 79,69 | −122 484 | 4 385 580 |
2018-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 583 | 56 570 | −5,96 | 81,36 | −291 513 | 4 602 535 | |
2018-03-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −4 368 | 60 153 | −6,77 | 83,90 | −366 475 | 5 046 837 |
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 41 040 | 41 040 | |||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 840 | 64 521 | 24,84 | ||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 651 | 51 681 | −6,60 | 83,57 | −305 114 | 4 318 981 | |
2018-03-13 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 972 | 55 332 | −5,10 | 82,39 | −244 863 | 4 558 803 |
2018-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 614 | 58 304 | −2,69 | 79,86 | −128 894 | 4 656 157 | |
2018-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 529 | 59 918 | 26,44 | ||||
2017-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 166 | 0 | −100,00 | |||
2017-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −1 355 | 2 166 | −38,48 | |||
2017-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 166 | 47 944 | −4,32 | 95,00 | −205 770 | 4 554 680 |
2017-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 166 | 50 110 | 4,52 | 37,46 | 81 138 | 1 877 121 |
2017-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 355 | 47 944 | −2,75 | 95,00 | −128 725 | 4 554 680 |
2017-09-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 1 355 | 49 299 | 2,83 | 37,46 | 50 758 | 1 846 741 |
2017-09-21 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Stock Option |
A - Award | 22 500 | 22 500 | |||||
2017-09-21 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Stock Option |
A - Award | 33 750 | 33 750 | |||||
2017-09-21 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
A - Award | 9 000 | 22 500 | 66,67 | ||||
2017-09-21 |
|
4 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
A - Award | 13 500 | 13 500 | |||||
2017-09-21 | 3 | NKTR |
NEKTAR THERAPEUTICS
Common Stock |
0 | ||||||||
2017-06-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 004 | 47 944 | −2,05 | 89,61 | −89 968 | 4 296 262 |
2017-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 488 | 48 948 | −2,95 | 90,72 | −134 991 | 4 440 563 | |
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 50 436 | −2,13 | 91,50 | −100 284 | 4 614 894 | |
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −3 498 | 0 | −100,00 | |||
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −988 | 0 | −100,00 | |||
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 498 | 51 532 | −6,36 | 99,00 | −346 302 | 5 101 668 |
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 498 | 55 030 | 6,79 | 38,59 | 134 988 | 2 123 608 |
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −988 | 51 532 | −1,88 | 99,00 | −97 812 | 5 101 668 |
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 988 | 52 520 | 1,92 | 28,23 | 27 891 | 1 482 640 |
2017-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −302 | 51 532 | −0,58 | 96,74 | −29 215 | 4 985 206 |
2017-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 302 | 51 834 | 0,59 | 70,30 | 21 232 | 3 644 138 | |
2017-03-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 890 | 51 532 | −7,02 | 89,15 | −346 794 | 4 594 078 |
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 39 480 | 39 480 | |||||
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 200 | 55 422 | 28,23 | ||||
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 288 | 43 222 | −7,07 | 92,50 | −304 140 | 3 998 035 | |
2017-03-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 46 510 | −9,71 | 90,56 | −452 800 | 4 211 946 |
2017-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 749 | 51 510 | −3,28 | 93,95 | −164 319 | 4 839 364 | |
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 917 | 53 259 | 28,83 | 95,61 | 1 139 396 | 5 092 146 | |
2016-09-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −18 467 | 41 342 | −30,88 | 95,61 | −1 765 648 | 3 952 750 |
2016-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 488 | 59 809 | −2,43 | 90,00 | −133 920 | 5 382 810 | |
2016-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 61 297 | −1,76 | 82,71 | −90 650 | 5 069 875 | |
2016-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −679 | 62 393 | −1,08 | 80,80 | −54 863 | 5 041 354 | |
2016-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −415 | 63 072 | −0,65 | 86,03 | −35 701 | 5 425 826 |
2016-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 415 | 63 487 | 0,66 | 51,26 | 21 275 | 3 254 598 | |
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock |
A - Award | 36 280 | 36 280 | |||||
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 16 190 | 63 072 | 34,53 | ||||
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 255 | 46 882 | −2,61 | 88,42 | −110 970 | 4 145 424 |
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 395 | 48 137 | −4,74 | 89,57 | −214 520 | 4 311 631 | |
2016-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −17 656 | 50 532 | −25,89 | 81,87 | −1 445 497 | 4 137 055 | |
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 5 883 | 68 188 | 9,44 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 19 840 | 62 305 | 46,72 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 6 860 | 42 465 | 19,27 | ||||
2015-11-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −26 | 35 605 | −0,07 | 117,56 | −3 057 | 4 185 724 |
2015-11-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 26 | 35 631 | 0,07 | 57,26 | 1 489 | 2 040 356 | |
2015-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −3 000 | 39 700 | −7,03 | ||||
2015-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 000 | 35 605 | −7,77 | 150,00 | −450 000 | 5 340 750 |
2015-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 000 | 38 605 | 8,43 | 63,10 | 189 300 | 2 435 976 |
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 362 | 35 605 | −3,68 | 122,35 | −166 646 | 4 356 411 |
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 488 | 36 967 | −3,87 | 120,46 | −179 244 | 4 453 045 | |
2015-06-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −377 | 38 455 | −0,97 | 123,76 | −46 657 | 4 759 122 |
2015-06-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −413 | 38 832 | −1,05 | 125,57 | −51 860 | 4 876 134 | |
2015-05-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 625 | 39 245 | −3,98 | 126,55 | −205 647 | 4 966 545 |
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 40 870 | −2,61 | 122,78 | −134 567 | 5 018 019 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −679 | 41 966 | −1,59 | 121,66 | −82 607 | 5 105 584 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −8 671 | 2 166 | −80,01 | ||||
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −808 | 1 355 | −37,36 | ||||
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −5 258 | 0 | −100,00 | ||||
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −2 642 | 978 | −72,98 | ||||
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −3 125 | 0 | −100,00 | ||||
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −625 | 0 | −100,00 | ||||
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −12 502 | 0 | −100,00 | ||||
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −388 | 42 645 | −0,90 | 119,20 | −46 248 | 5 083 071 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −33 631 | 43 033 | −43,87 | 119,14 | −4 006 794 | 5 126 947 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 8 671 | 76 664 | 12,75 | 37,46 | 324 816 | 2 871 833 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 808 | 67 993 | 1,20 | 37,46 | 30 268 | 2 547 018 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 5 258 | 67 185 | 8,49 | 28,23 | 148 433 | 1 896 633 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 2 642 | 61 927 | 4,46 | 28,23 | 74 584 | 1 748 199 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 125 | 59 285 | 5,56 | 21,51 | 67 219 | 1 275 220 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 625 | 56 160 | 1,13 | 21,51 | 13 444 | 1 208 002 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 12 502 | 55 535 | 29,05 | 38,59 | 482 452 | 2 143 096 | |
2015-05-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 943 | 43 033 | 2,24 | 51,26 | 48 341 | 2 206 022 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 23 900 | 23 900 | |||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 500 | 42 090 | 33,24 | ||||
2014-12-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | −12 000 | 12 502 | −48,98 | ||||
2014-12-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −12 000 | 31 590 | −27,53 | 91,01 | −1 092 161 | 2 875 113 | |
2014-12-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 12 000 | 43 590 | 37,99 | 38,59 | 463 080 | 1 682 138 | |
2014-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −47 | 31 590 | −0,15 | 83,54 | −3 926 | 2 639 029 |
2014-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 47 | 31 637 | 0,15 | 31,26 | 1 469 | 988 973 | |
2014-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 42 700 | 42 700 | |||||
2014-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 400 | 31 590 | 56,46 | ||||
2014-06-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −377 | 20 190 | −1,83 | 57,83 | −21 804 | 1 167 683 |
2014-06-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −413 | 20 567 | −1,97 | 57,96 | −23 937 | 1 192 063 | |
2014-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 004 | 20 980 | −4,57 | 56,91 | −57 136 | 1 193 934 |
2014-05-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 21 984 | −4,75 | 57,44 | −62 954 | 1 262 761 | |
2014-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −478 | 23 080 | −2,03 | 58,18 | −27 809 | 1 342 760 |
2014-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −522 | 23 558 | −2,17 | 59,30 | −30 955 | 1 396 989 | |
2014-05-13 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −621 | 24 080 | −2,51 | 57,96 | −35 992 | 1 395 624 |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −679 | 24 701 | −2,68 | 56,78 | −38 554 | 1 402 523 | |
2014-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −666 | 25 380 | −2,56 | 59,55 | −39 661 | 1 511 402 |
2014-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 666 | 26 046 | 2,62 | 29,70 | 19 780 | 773 540 | |
2014-03-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | −14 812 | 5 258 | −73,80 | |||
2014-03-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | −2 558 | 3 125 | −45,01 | |||
2014-03-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −17 370 | 25 380 | −40,63 | 78,63 | −1 365 831 | 1 995 670 |
2014-03-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 14 812 | 42 750 | 53,02 | 28,23 | 418 143 | 1 206 832 |
2014-03-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 558 | 27 938 | 10,08 | 21,51 | 55 023 | 600 946 |
2014-02-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 500 | 25 380 | 70,56 | ||||
2013-12-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | −9 192 | 625 | −93,63 | ||||
2013-12-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | −625 | 0 | −100,00 | ||||
2013-12-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | −3 125 | 0 | −100,00 | ||||
2013-12-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | −84 | 0 | −100,00 | ||||
2013-12-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −13 026 | 14 880 | −46,68 | 69,55 | −906 010 | 1 034 964 | |
2013-12-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 9 192 | 27 906 | 49,12 | 21,51 | 197 720 | 600 258 | |
2013-12-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 750 | 18 714 | 25,06 | 14,39 | 53 962 | 269 294 | |
2013-12-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 84 | 14 964 | 0,56 | 17,86 | 1 500 | 267 257 | |
2013-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −99 | 14 880 | −0,66 | 63,16 | −6 253 | 939 821 |
2013-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 99 | 14 979 | 0,67 | 27,91 | 2 763 | 417 996 | |
2013-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −493 | 14 880 | −3,21 | 58,34 | −28 763 | 868 153 |
2013-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −297 | 15 373 | −1,90 | 62,70 | −18 622 | 963 887 | |
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 49 000 | 49 000 | |||||
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 8 400 | 15 670 | 115,54 | ||||
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 248 | 7 270 | −14,65 | 69,26 | −86 431 | 503 487 |
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −752 | 8 518 | −8,11 | 67,68 | −50 895 | 576 498 | |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −811 | 9 270 | −8,04 | 66,00 | −53 528 | 611 847 |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −489 | 10 081 | −4,63 | 65,32 | −31 941 | 658 491 | |
2013-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −797 | 10 570 | −7,01 | 64,52 | −51 420 | 681 950 |
2013-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 797 | 11 367 | 7,54 | 23,20 | 18 490 | 263 714 | |
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −5 000 | 15 500 | −24,39 | ||||
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 10 570 | −32,11 | 65,00 | −325 000 | 687 050 |
2013-04-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 15 570 | 47,30 | 21,51 | 107 550 | 334 911 |
2013-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −4 000 | 20 500 | −16,33 | ||||
2013-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −4 000 | 10 570 | −27,45 | 60,00 | −240 000 | 634 200 |
2013-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 4 000 | 14 570 | 37,84 | 21,51 | 86 040 | 313 401 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −3 000 | 93 034 | −3,12 | ||||
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 000 | 10 570 | −22,11 | 55,00 | −165 000 | 581 350 |
2013-01-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 000 | 13 570 | 28,38 | 21,51 | 64 530 | 291 891 |
2012-11-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −2 500 | 96 034 | −2,54 | ||||
2012-11-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −2 500 | 96 034 | −2,54 | ||||
2012-11-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −916 | 98 534 | −0,92 | ||||
2012-11-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | 5 916 | 10 570 | 127,12 | 48,31 | 285 817 | 510 663 | |
2012-11-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 2 500 | 16 486 | 17,88 | 21,51 | 53 775 | 354 614 | |
2012-11-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 916 | 13 986 | 7,01 | 17,86 | 16 360 | 249 790 | |
2012-11-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 2 500 | 13 070 | 23,65 | 14,39 | 35 975 | 188 077 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −265 | 10 570 | −2,45 | 48,11 | −12 750 | 508 565 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 265 | 10 835 | 2,51 | 21,76 | 5 766 | 235 770 | |
2012-09-14 | 3 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
10 570 |